'Don't rush through regulation at the expense of innovation'

By Norman Williams2012-01-26T00:00:00

The PIP breast implant scandal has raised difficult questions for trusts and clinicians about the faith they place in the reliability of medical devices they use.

You need to be signed in to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All of HSJ.co.uk and our HSJ mobile app
News and insight on all areas of public funded healthcare
Expert commentary, insight and analysis from industry leaders
9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

to HSJ

Sign into your account here